Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.

Cancer discovery - 1 Oct 2013

Ellis Matthew J, Gillette Michael, Carr Steven A, Paulovich Amanda G, Smith Richard D, Rodland Karin K, Townsend R Reid, Kinsinger Christopher, Mesri Mehdi, Rodriguez Henry, Liebler Daniel C

Abstract excerpt

The National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium is applying the latest generation of proteomic technologies to genomically annotated tumors from The Cancer Genome Atlas (TCGA) program, a joint initiative of the NCI and the National Human Genome Research Institute....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colonic Neoplasms
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Genomics

Share to Molecular Sequence Annotation

Share to Ovarian Neoplasms

Share to Proteomics

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 24124232
DOI: 10.1158/2159-8290.CD-13-0219
PMCID: PMC3800055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24124232-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.PMID 24124232Read ↗

Linking cancer genome to proteome: NCI's investment into proteogenomicsSemantic proximity Read ↗

Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathwaysSemantic proximity Read ↗

Integration of proteomics in the molecular tumor boardSemantic proximity Read ↗

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read ↗

Global impact of germline structural variation on the cancer proteome.Semantic proximity Read ↗

The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical–genomic driver associationsSemantic proximity Read ↗

Simplified and unified access to cancer proteogenomic dataSemantic proximity Read ↗

Integration and analysis of CPTAC proteomics data in the context of cancer genomics in the cBioPortalSemantic proximity Read ↗

Tumor Profiling: Adding Proteomics to Genomics.Semantic proximity Read ↗

A pan-cancer proteomic perspective on The Cancer Genome AtlasSemantic proximity Read ↗

Beyond the genome and proteome: targeting protein modifications in cancerSemantic proximity Read ↗

CancerProteome: a resource to functionally decipher the proteome landscape in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.